Medical Devices Startups

1 investor

Everest is an AI platform that automates regulatory, clinical, and commercial document workflows for pharmaceutical, medtech, and contract research organizations (CROs), generating submission-ready documents and associated statistical analyses from source data.

1 investor

Evergreen Theragnostics manufactures radiopharmaceutical therapeutics and diagnostics for cancer treatment and develops novel radiotherapeutic agents for cancer patients. The company offers high-quality manufacturing services and handles product registration and commercialization for partner companies.

1 investor

EVerMed is a company focused on extracellular vesicle biology and pharmaceutical development, combining academic expertise with industry experience in drug development and regenerative medicine.

1 investor

eversyn produces human milk oligosaccharides and nucleotide sugars using proprietary cell-free biocatalytic technology for food and nutrition applications. The company emerged from the Max Planck Institute Magdeburg as a spin-out translating enzyme and bioprocess research into commercial production.

1 investor

EVerZom develops exosome formulation technologies that modify cells to release exosomes with enhanced therapeutic properties, designed for targeted delivery to specific tissue sites. The company creates formulated exosome drugs for treating pathologies through local or systemic administration routes.

1 investor

Evestia Clinical is a clinical research organization providing clinical trial services for biotech companies across oncology, rare disease, neurology, immunology, and inflammation. The company was established in 1996 and recently rebranded to reflect its expanded focus as a global clinical research provider.

1 investor

EviCure is a pre-clinical biopharmaceutical company developing extracellular vesicle-based therapies for cancer treatment using AI and disease modeling. The company uses AI-powered platforms to identify EV subpopulations with therapeutic potential and enables targeted drug delivery for oncology applications.

1 investor

Evido Health uses data models to identify individuals at risk of chronic liver disease, specifically fatty liver disease, enabling early detection and clinical intervention. The company targets healthcare providers and patients for disease prevention.

1 investor

A company that developed a proprietary platform for single-cell immune profiling from small plasma volumes to enable non-invasive diagnostics. Founded from University of Zurich research, it applies immunology and data science to clinical diagnostics.

1 investor

evismo provides diagnostic services using sensor technology to detect cardiac arrhythmias, stress, and sleep apnea for general practitioners and specialists.

1 investor

EvoEndo makes an FDA-cleared endoscopy system for sedation-free transnasal and traditional transoral procedures in adult and pediatric patients. Its offering combines a single-use ultra-slim flexible gastroscope with four-way steering, a portable controller, and a virtual reality-based patient distraction system, aimed at gastroenterologists treating conditions such as eosinophilic esophagitis.

1 investor

Evoke Pharma develops treatments for gastrointestinal disorders, focusing on advancing and commercializing GIMOTI, a nasal spray formulation for diabetic gastroparesis. The company operates in the pharmaceutical and specialty care industry.

1 investor

Evolution Healthcare operates a network of private hospitals and specialist day facilities in New Zealand providing surgical, maternity, and healthcare services. The group delivers comprehensive healthcare and wellbeing services through hospitals and specialist practitioners.

1 investor

ExactCare is a pharmacy service that delivers medications to patients' homes while providing ongoing clinical support to optimize medication effectiveness and safety. The company works with insurance providers and doctors to manage patient medications and improve health outcomes.

1 investor

Exalt Health is a post-acute care healthcare organization that operates hospitals and care facilities based on an operational model focused on efficiency and clinical outcomes. The company serves patients requiring rehabilitation, long-term acute care, and skilled nursing services.

1 investor

Excel Venture Management is a venture capital firm that invests in healthcare and life sciences companies across various sectors and stages, with a focus on businesses that lower costs and improve outcomes.

1 investor

Excite Pharma is an FDA-inspected, GMP/GLP-compliant contract research and manufacturing organization providing CMC services to pharmaceutical companies, with a focus on aseptic manufacturing and analytical chemistry across drug substance, drug product, and excipients. Its services span small-scale development, clinical and commercial manufacturing, method development and validation, stability programs, release testing, dissolution, residual solvent and metal analysis, and extractables and leachables testing.

1 investor

Exela Pharma Sciences operates cGMP-compliant contract development and manufacturing organization (CDMO) and fill-finish facilities producing injectable pharmaceuticals including vials, pre-filled syringes, and IV bags. The company serves pharmaceutical manufacturers seeking US-based contract manufacturing and development services.

1 investor

Exer.ai is an artificial intelligence company that helps organizations and individuals optimize performance across technical systems, workforce capabilities, and personal development.

1 investor

Exergen makes temporal artery thermometers and other infrared temperature measurement products for consumer, professional/OEM, and industrial use. Its products, including clinical-grade thermometers, are FDA approved and sold in 48 countries.

1 investor

ExMedio provides an IT platform called Hipokura that enables physicians across specialties to share clinical knowledge, seek specialist consultations, and discuss cases to improve diagnostic and treatment quality. The platform serves doctors in Japan with over 70,000 registered physicians and includes specialized consultation features for dermatology, ophthalmology, cardiology, pulmonology, and rare diseases.

1 investor

Exogenus develops therapeutic exosomes derived from umbilical cord blood cells to treat autoimmune diseases through immune system rebalancing. The company targets multiple autoimmune disease indications where existing pharmaceutical treatments carry significant side effects.

1 investor

Exolvo Biosciences develops drug delivery technology. The page does not provide sufficient detail about the company's specific products, markets served, or business model beyond the co-founder's background.

1 investor